Quantcast

Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza.

Research paper by Kazuhiko K Matsuo, Sachiko S Hirobe, Yayoi Y Yokota, Yurika Y Ayabe, Masashi M Seto, Ying-Shu YS Quan, Fumio F Kamiyama, Takahiro T Tougan, Toshihiro T Horii, Yohei Y Mukai, Naoki N Okada, Shinsaku S Nakagawa

Indexed on: 21 Apr '12Published on: 21 Apr '12Published in: Journal of Controlled Release



Abstract

Transcutaneous immunization (TCI) is an attractive alternative vaccination route compared to the commonly used injection systems. We previously developed a dissolving microneedle array for use as a TCI device, and reported that TCI with the dissolving microneedle array induced an immune response against model antigens. In the present study, we investigated the vaccination efficacy against tetanus and diphtheria, malaria, and influenza using this vaccination system. Our TCI system induced substantial increases in toxoid-specific IgG levels and toxin-neutralizing antibody titer and induced the production of anti-SE36 IgG, which could bind to malaria parasite. On influenza HA vaccination, robust antibody production was elicited in mice that provided complete protection against a subsequent influenza virus challenge. These findings demonstrate that TCI using a dissolving microneedle array can elicit large immune responses against infectious diseases. Based on these results, we are now preparing translational research for human clinical trials.